RION Appoints Five Experts To Advisory Boards
25 Sep 2024 //
BUSINESSWIRE
RION Initiates Phase 1b Study Of PEP™ For Knee Osteoarthritis
10 Sep 2024 //
BUSINESSWIRE
RION Doses First Patient In Phase 2 Exosome Study For Diabetic Ulcers
07 May 2024 //
BUSINESSWIRE